GenSight Biologics Statistics

Total Valuation

LON:0RIM has a market cap or net worth of GBP 29.43 million. The enterprise value is 43.64 million.

Market Cap	29.43M
Enterprise Value	43.64M

Important Dates

The next estimated earnings date is Friday, September 19, 2025.

Earnings Date	Sep 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+98.18%
Shares Change (QoQ)	+31.43%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	89.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.55
PB Ratio	-1.32
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.77
EV / Sales	19.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.08

Financial Position

The company has a current ratio of 0.24

Current Ratio	0.24
Quick Ratio	0.20
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.48
Interest Coverage	-10.18

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-99.39%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	133.32%
Revenue Per Employee	135,675
Profits Per Employee	-723,650
Employee Count	16
Asset Turnover	0.26
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.64% in the last 52 weeks. The beta is 2.25, so LON:0RIM's price volatility has been higher than the market average.

Beta (5Y)	2.25
52-Week Price Change	-43.64%
50-Day Moving Average	0.26
200-Day Moving Average	0.33
Relative Strength Index (RSI)	47.42
Average Volume (20 Days)	6,983

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0RIM had revenue of GBP 2.17 million and -11.58 million in losses. Loss per share was -0.12.

Revenue	2.17M
Gross Profit	2.17M
Operating Income	-13.08M
Pretax Income	-11.56M
Net Income	-11.58M
EBITDA	-12.95M
EBIT	-13.08M
Loss Per Share	-0.12

Full Income Statement

Balance Sheet

The company has 2.04 million in cash and 15.81 million in debt, giving a net cash position of -13.77 million.

Cash & Cash Equivalents	2.04M
Total Debt	15.81M
Net Cash	-13.77M
Net Cash Per Share	n/a
Equity (Book Value)	-22.26M
Book Value Per Share	-0.17
Working Capital	-14.29M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.70 million and capital expenditures -827, giving a free cash flow of -10.70 million.

Operating Cash Flow	-10.70M
Capital Expenditures	-827
Free Cash Flow	-10.70M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-602.44%
Pretax Margin	-532.57%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0RIM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-98.18%
Shareholder Yield	-98.18%
Earnings Yield	-39.35%
FCF Yield	-36.36%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0RIM has an Altman Z-Score of -7.81. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.81
Piotroski F-Score	n/a